<DOC>
	<DOCNO>NCT01124877</DOCNO>
	<brief_summary>The purpose study assess safety tolerability ziprasidone long-term open label study child adolescent ( age 10-17 ) Bipolar I Disorder ( Manic Mixed ) .</brief_summary>
	<brief_title>Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder ( Manic Or Mixed )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>The subject must receive study medication Study A1281196 . In investigator 's opinion , subject must likely continue benefit antipsychotic therapy must free clinically significant safety concern precede double blind study . Subjects require treatment drug know consistently prolong QT interval . Subjects judge investigator imminent risk suicide .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Children Adolescents Bipolar I Disorder ( manic mixed )</keyword>
</DOC>